| Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies M Giardiello, NJ Liptrott, TO McDonald, D Moss, M Siccardi, P Martin, ... Nature communications 7 (1), 13184, 2016 | 55 | 2016 |
| Inhibitory effects of commonly used excipients on P-glycoprotein in vitro R Gurjar, CYS Chan, P Curley, J Sharp, J Chiong, S Rannard, M Siccardi, ... Molecular pharmaceutics 15 (11), 4835-4842, 2018 | 52 | 2018 |
| Dual-stimuli responsive injectable microgel/solid drug nanoparticle nanocomposites for release of poorly soluble drugs AR Town, M Giardiello, R Gurjar, M Siccardi, ME Briggs, R Akhtar, ... Nanoscale 9 (19), 6302-6314, 2017 | 36 | 2017 |
| Clinical profile of HIV infected patients attending a HIV referral clinic in Pune, India M Antwal, R Gurjar, S Chidrawar, J Pawar, S Gaikwad, N Panchal, V Kale, ... Indian Journal of Medical Research 140 (2), 271-277, 2014 | 20 | 2014 |
| Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected … L Dickinson, R Gurjar, W Stöhr, S Bonora, A Owen, A D’avolio, A Cursley, ... Journal of Antimicrobial Chemotherapy 75 (3), 628-639, 2020 | 14 | 2020 |
| Investigation of molecular mechanisms regulating drug-drug interactions in antiretroviral therapy R Gurjar PQDT-UK & Ireland, 2019 | 1 | 2019 |
| Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001 … R Gurjar, L Dickinson, D Carr, W Stöhr, S Bonora, A Owen, A D’Avolio, ... The Pharmacogenomics Journal 23 (1), 14-20, 2023 | | 2023 |
| Association of SLCO1B1 521T> C (rs4149056) with darunavir/ritonavir (DRV/r) plasma concentrations in HIV-infected individuals enrolled in the NEAT001/ANRS143 study R Gurjar, M Boffito, A D'Avolio, C Schwimmer, Y Yazdanpanah, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 19, 2016 | | 2016 |
| P301 Interactions between HIV and HCV therapies: how common and who wins? A Torkington, J Barnes, S Cripps, K Lee, N Marshall, H Morgan, A Pratt, ... | | |
Tom O. McDonaldUniversity of ManchesterDirección de correo verificada de liv.ac.uk
